SUMMARY OF FINAL EVALUATIONS.
- Published in:
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2022, v. 130, p. 367
- Publication type:
- Article
Works matching IS 10171606 AND DT 2022 AND VI 130
Results: 12
1
2
ANNEX.
- Published in:
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2022, v. 130, p. 361
- Publication type:
- Article
3
LIST OF ABBREVIATIONS.
- Published in:
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2022, v. 130, p. 359
- Publication type:
- Article
4
ISOPHORONE.
- Published in:
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2022, v. 130, p. 307
- Publication type:
- Article
5
N-METHYLOLACRYLAMIDE.
- Published in:
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2022, v. 130, p. 273
- Publication type:
- Article
6
DIPHENYLAMINE.
- Published in:
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2022, v. 130, p. 229
- Publication type:
- Article
7
1,2-DIPHENYLHYDRAZINE.
- Published in:
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2022, v. 130, p. 203
- Publication type:
- Article
8
1,1,1-TRICHLOROETHANE.
- Published in:
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2022, v. 130, p. 43
- Publication type:
- Article
9
GENERAL REMARKS.
- Published in:
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2022, v. 130, p. 39
- Publication type:
- Article
10
PREAMBLE.
- Published in:
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2022, v. 130, p. 7
- Publication type:
- Article
11
LIST OF PARTICIPANTS.
- Published in:
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2022, v. 130, p. 3
- Publication type:
- Article
12
NOTE TO THE READER.
- Published in:
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2022, v. 130, p. 1
- Publication type:
- Article